Improving understanding of chromatin regulatory proteins and potential implications for drug discovery

Research output: Contribution to journalReview ArticleResearchpeer-review

1 Citation (Scopus)


Many epigenetic-based therapeutics, including drugs such as histone deacetylase inhibitors, are now used in the clinic or are undergoing advanced clinical trials. The study of chromatin-modifying proteins has benefited from the rapid advances in high-throughput sequencing methods, the organized efforts of major consortiums and by individual groups to profile human epigenomes in diverse tissues and cell types. However, while such initiatives have carefully characterized healthy human tissue, disease epigenomes and drug-epigenome interactions remain very poorly understood. Reviewed here is how high-throughput sequencing improves our understanding of chromatin regulator proteins and the potential implications for the study of human disease and drug development and discovery.

Original languageEnglish
Pages (from-to)435-445
Number of pages11
JournalExpert Review of Proteomics
Issue number4
Publication statusPublished - 2 Apr 2016


  • chromatin modifications
  • Epigenetics
  • HDAC inhibitors
  • high-throughput sequencing
  • histone acetylation

Cite this